HomeNewsTrendsEntertainmentMultiplexes PVR, INOX restart operations after many states allow cinemas to reopen

Multiplexes PVR, INOX restart operations after many states allow cinemas to reopen

Almost 100 percent of markets have reopened for theatres in India barring Kerala and Maharashtra, says film producer and trade business analyst Girish Johar.

July 30, 2021 / 19:06 IST
Story continues below Advertisement
Along with capacity expansion, content will be key in reviving the COVID-19 pandemic-hit cinema business.
Along with capacity expansion, content will be key in reviving the COVID-19 pandemic-hit cinema business.

Majority of the multiplex chains have restarted operations as many states have allowed cinemas to reopen including big markets like Delhi.

Multiplex operators PVR and INOX both announced reopening in select markets.

Story continues below Advertisement

INOX is reopening from Juky 30 in Delhi NCR, Uttar Pradesh, Rajasthan, Gujarat, Jharkhand, Madhya Pradesh and down south in states like Telangana, Karnataka, Andhra Pradesh, among others.

While PVR operates 842 screens, INOX has 637 screens.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show